Aspire Growth Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$464K Sell
2,098
-134
-6% -$32.8K 0.32% 71
2025
Q4
$566K Sell
2,232
-197
-8% -$49.5K 0.39% 59
2025
Q3
$601K Buy
2,429
+21
+0.9% +$5.03K 0.44% 54
2025
Q2
$578K Sell
2,408
-27
-1% -$6.29K 0.47% 50
2025
Q1
$548K Buy
+2,435
New +$536K 0.49% 51

Other funds holding STE

Aspire Growth Partners's STE Position: Q1 2026 in Review

Aspire Growth Partners reduced its Steris (STE) stake by 6% in Q1 2026, selling an estimated $32.8K and leaving 2,098 shares worth $464K. The position accounts for 0.32% of the portfolio, ranked #71.

Aspire Growth Partners first reported a position in STE in Q1 2025 and has held it in 5 quarters since. The position peaked at $601K in Q3 2025. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Aspire Growth Partners held 2,098 shares of Steris worth $464K as of Q1 2026.
  • Aspire Growth Partners sold 134 Steris shares in Q1 2026, an estimated $32.8K.
  • Steris made up 0.32% of Aspire Growth Partners's portfolio in Q1 2026, its #71 holding.
  • Aspire Growth Partners first reported a position in Steris in Q1 2025 and has held it in 5 quarters since.
  • Aspire Growth Partners's Steris position peaked at $601K in Q3 2025.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Aspire Growth Partners's 13F filing for Q1 2026, filed 17 Apr 2026.